In G 0 /G 1 cell cycle-arrested mouse Y1 adrenocortical cells, short pulses (30 min to 2 h) of fibroblast growth factor-2 (FGF2) (5 pM to 1 nM) caused induction of cFos protein by 2 h and onset of DNA synthesis stimulation by 8-9 h. FGF2 dose-response curves for cFos induction (percent labeled nuclei with a specific anti-cFos antibody) and DNA synthesis stimulation (bromodeoxyuridine labeling index) were linearly correlated with a correlation coefficient of 0·969. Inhibition of cFos and cJun protein induction with antisense oligodeoxynucleotides (ODNs) to cfos and cjun mRNAs blocked DNA synthesis stimulation by FGF2. Pulses (up to 2 h) of synthetic ACTH 39 (1 pM to 1 nM) and natural porcine corticotropin A (10 pg/ml to 1 µg/ml) also induced cFos protein and DNA synthesis in G 0 /G 1 -arrested Y1 adrenal cells. ACTH dose-response curves for cFos induction and DNA synthesis stimulation were not correlated. But cfos and/or cjun antisense ODNs blocked DNA synthesis stimulation by ACTH. Thus, signals initiated in FGF2 and ACTH receptors appear to converge to the induction of cfos and cjun genes to trigger DNA synthesis stimulation.
Introduction
The molecular mechanisms by which adrenocorticotropin (ACTH) causes its growth effects on adrenal cortex remained obscure for decades. In the intact organism ACTH seems to be a mitogen, but in cell lines and primary cultures of mouse, rat, cow and human adrenocortical cells ACTH appears to be a growth inhibitory hormone (Hornsby 1985) .
We recently reported, for the first time, that short pulses of ACTH trigger a mitogenic response in G 0 /G 1 -arrested Y1 adrenocortical cells, resembling fibroblast growth factor-2 (FGF2), albeit with a reduced intensity (Armelin et al. 1996 , Lotfi et al. 1997 ). These observations suggested that the mouse Y1 adrenocortical cell line (Yasumura et al. 1966 , Schimmer 1981 ) is a cell system experimentally useful to access cellular and molecular mechanisms of growth control activated by ACTH receptors in adrenocortical cells.
Both ACTH and FGF2, respectively, induce the fos and jun genes in G 0 /G 1 -arrested Y1 adrenocortical cells (Kimura & Armelin 1990 , Kimura et al. 1993 , Lotfi et al. 1997 , following the same pattern of induction displayed by G 0 -arrested Balb3T3 fibroblasts stimulated by FGF2. Fos (cFos, FosB, Fra1 and Fra2) and Jun (cJun, JunB and JunD) proteins dimerize via a leucine zipper domain to form heterodimers (Fos-Jun) and homodimers (Jun-Jun), making up the series of transcription factors denominated AP1 (for review see Angel & Karin 1991) . AP1 factors seem to play a critical role in the control of G 0 <G 1 <S transition of the cell cycle. Quiescent G 0 -arrested fibroblasts exhibit very low levels of AP1 factors and upon stimulation by peptide growth factors, like FGF2 and platelet-derived growth factor, rapidly induce the fos and jun genes in an ordered fashion (Kovary & Bravo 1991a ,b, Cook et al. 1999 . Blocking of cFos and cJun proteins induction with an antisense technique (Holt et al. 1986 , Nishikura & Murray 1987 or their activities with specific antibodies (Riabowol et al. 1988 , Kovary & Bravo 1991b ) is sufficient to block the G 0 <G 1 <S transition in G 0 -arrested fibroblasts stimulated with growth factors.
In this paper we show that blocking cFos and cJun protein synthesis with antisense phosphorotioate oligodeoxynucleotides (ODNs) is sufficient to inhibit DNA synthesis stimulated by pulses of FGF2 and/or ACTH in G 0 /G 1 -arrested Y1 adrenocortical cells. These results indicate that cFos and cJun protein induction is an obligatory step in the mechanisms triggered by FGF2 and ACTH to elicit a mitogenic response in Y1 adrenocortical cells.
Materials and Methods
Cells and culture procedures Y1 mouse adrenocortical carcinoma cells (Yasumura et al. 1966 , Schimmer 1981 ) are a clonal cell line obtained from the American Type Culture Collection (Rockville, MD, USA) in 1973. Frozen stocks were kept in liquid nitrogen and routinely grown in Dulbecco's modified Eagle's medium with heat-inactivated 10% fetal calf serum (FCS), at 37 C in a humidified atmosphere of 5% CO 2 , 95% air.
Synthetic ACTH peptides, natural porcine corticotropin A and recombinant bovine FGF2
Synthetic ACTH 39 , ACTH 24 and ACTH 7-38 and natural porcine corticotropin A batch 96H0687 (90 U/mg) were purchased from Sigma (St Louis, MO, USA). These Sigma peptide products were analyzed by HPLC and chemically characterized by mass spectrometry and N-terminal sequencing in the laboratory of Prof. L Juliano, at the Escola Paulista de Medicina (UNIFESP, São Paulo), where synthetic ACTH peptides were also synthesized. Bovine recombinant FGF2 was prepared in the laboratory of Prof. A Gambarini, from this Department of Biochemistry.
Phosphorotioate ODNs, antibodies and other reagents 18-mers of phosphorotioate ODNs were purchased from Gibco BRL (Life Technologies, Inc., São Paulo, Brazil) and Bio-Synthesis, Inc. (Lewisville, TX, USA) with the following sequences: cfos antisense 5 -GGCGTTGAAA CCCGAGAA-3 and respective sense; cjun antisense 5 -CGTTTCCATCTTGCAGT-3 and respective sense (Colotta et al. 1992) . Rabbit polyclonal antibodies to mouse cFos and JunD proteins were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA); mouse monoclonal anti-bromodeoxyuridine (BrdU) from Amersham Pharmacia Biotech (São Paulo, Brazil); lipofectin from Gibco BRL; and Vectastain Elite ABC kit for immunoperoxidase staining from Vector Labs Inc. (Burlingame, CA, USA).
Protocols of antisense experiments
Y1 cells were seeded on coverslips and starved in serumfree medium (SFM) for 48 h. Fresh solutions of ODNs (0·2-40 µM) and lipofectin (20 µg/ml), in SFM, were mixed in equal volumes and incubated for 30 min to allow for complex formation. Pairs of coverslips were preincubated for 3-4 h in 1 ml fresh SFM containing pre-formed ODN-lipofectin complexes, with ratios of ODN to lipofectin increasing from 0·1 µM:10 µg to 20 µM:10 µg. At time zero, 100 mU/ml porcine corticotropin A or 1 nM FGF2 were added to the medium and incubated for 2 h. To test the effect of ODNs in cFos synthesis the experiment was terminated at 2 h by rinsing the coverslips with PBS and fixing the cells with 3·7% formaldehyde in PBS for 20 min. On the other hand, when the aim was to estimate the effects of ODNs in S-phase entry by BrdU labeling, the experiment continued until 24 h. In this case, at 2 h the medium was sucked off and the coverslips were rinsed twice with PBS and re-incubated with fresh SFM containing ODNlipofectin complexes. At 12 h, 100 µM BrdU was added to the medium and at 24 h the cells were fixed with methanol and stored in a refrigerator for further processing.
Immunocytochemistry for cFos or JunD protein detection and BrdU labeling indices
Nuclear cFos or JunD immune complex was visualized by immunoperoxidase staining using the Vectastain Elite ABC kit and diaminobenzidine. Nuclei positive for immune complex were stained heavily brown, whereas negative nuclei appeared bluish stained with Harris' hematoxylin and differentiated with a saturated solution of Li 2 CO 3 . Percent of BrdU-labeled nuclei was estimated with anti-BrdU antibody as previously described (Lotfi et al. 1997) . Coverslips were randomly coded and 500-600 nuclei per coverslip were blindly counted. Results of independent experiments were pooled and statistically analyzed by Chi-square with 1 degree of freedom.
Results

Pulses of FGF2 and ACTH stimulate G 0 /G 1 -arrested Y1 adrenal cells to induce the cFos protein and to enter the S-phase of the cell cycle
Forty-eight hours of serum starvation in SFM caused cell cycle arrest at the G 0 /G 1 boundary in Y1 adrenal cells. G 0 /G 1 -arrested Y1 cells resumed growth upon FCS re-feeding or FGF2 sustained treatment, displaying an onset of DNA synthesis initiation by 8-9 h (Fig. 1 ). Short pulses of FGF2 (30 min to 2 h) were sufficient to trigger this growth response, exhibiting the same kinetics for S-phase entry ( Fig. 1 insert) .
Two-hour pulses of synthetic ACTH 39 and natural porcine corticotropin A resembled FGF2, inducing cFos protein and stimulating DNA synthesis, but the pattern of the dose-response curves were different (Fig. 2) . The dose-response curves for DNA synthesis stimulation and cFos induction by FGF2 were asymptotic and linearly correlated, displaying a coefficient of linear correlation of 0·969 and an ED 50 of 6-18 pM (Fig. 2a) . On the other hand, ACTH 39 and corticotropin A showed maximal stimulation of DNA synthesis at physiological concentrations, whereas the curves for cFos induction were shifted towards higher hormonal concentrations ( Fig. 2b and c).
We tested the effect of the synthetic inactive ACTH fragment 7-38, a well-known competitive inhibitor of ACTH 39 (Li et al. 1978) , on DNA synthesis stimulated by both ACTH 39 and corticotropin A, under the same conditions of the assays of Fig. 2b and c respectively. In the range 10 12 -10 9 M ACTH 39 and 10-1000 pg/ml corticotropin A, stimulation of DNA synthesis was inhibited 60-80% by ACTH 7-38 at 10 7 M; by itself, ACTH 7-38 at 10 7 M had no effect on DNA synthesis. These results suggest that stimulation of DNA synthesis by ACTH 39 and corticotropin A, in G 0 /G 1 -arrested Y1 cells, is mediated by specific ACTH receptors. . FCS (10%), 1 nM FGF2 and 100 M BrdU were added to the SFM at zero time; every hour a pair of coverslips was collected for each condition and processed to estimate percent BrdU-labeled nuclei. Results from two independent experiments were pooled and plotted as percent labeled nuclei as a function of time. () Control; () FGF2; () FCS. Insert: kinetics of S-phase entry after a sustained treatment or an initial 2 h pulse of FGF2. For sustained treatment (), 1 nM FGF2 and 100 M BrdU were added to SFM at zero time. For pulse treatment (), 1 nM FGF2 was added for the first 2 h, coverslips washed twice with PBS, incubated with fresh SFM and 100 M BrdU was incorporated in the last hour before collecting coverslips. The index of DNA synthesis stimulation for each time plotted in the graph is given by the expression: (percent labeled nuclei of treated cells minus percent labeled nuclei of untreated control cells) divided by percent labeled nuclei of untreated control cells.
Antisense ODNs to cfos and cjun mRNAs block Y1 adrenal cell entry into S-phase stimulated by ACTH and FGF2
The complex 20 µM cfos antisense/10 µg/ml lipofectin reduced cFos labeling by 30%, whereas 0·1 µM cfos antisense/10 µg/ml lipofectin caused 80% reduction in cFos labeling, (compare data in Table 1 ). Thus, with a low ODN to lipofectin ratio (0·1 µM:10 µg) we achieved a high degree of inhibition of cFos induction. Lipofectin alone and antisense ODN alone had respectively minimal or no effect on cFos labeling (see Fig. 3 and Table 1 ). The cFos labeling reduction effect of the cfos antisenselipofectin complex was sequence specific: cjun antisense and sense ODNs had no effect (Table 1 ). In addition, cfos antisense and sense and cjun antisense and sense had no effect on JunD labeling (not shown). Table 2 shows antisense inhibition of DNA synthesis stimulated by FGF2 and corticotropin A. To analyze the antisense effect we compared pairs of results obtained with an antisense and its respective sense ODN. The complexes of 0·1 µM ODN:10 µg/ml lipofectin yielded highly significant inhibition for both cfos and cjun antisense ODNs (Table 2) . But the pattern of antisense inhibition was different for FGF2 and corticotropin A (Fig. 4) . Combination of both cfos and cjun antisense ODNs was required to completely inhibit DNA synthesis stimulation by FGF2; cfos or cjun antisense ODN alone caused only about 50% inhibition (Fig. 4a ). Table 2 also shows that, in FGF2-treated cells, percent BrdU labeling for cfos plus cjun sense ODNs was significantly lower than for lipofectin alone, cfos sense ODN and cjun sense ODNs. However, this unspecific inhibitory effect of the sense ODNs is relatively small when compared with the complete inhibition of DNA synthesis stimulation by FGF2 caused by the combination of cfos and cjun antisense ODNs (Table 2 and Fig. 4a) .
On the other hand, DNA synthesis stimulated by corticotropin A was essentially abolished by either cfos or cjun antisense ODNs (Fig. 4b) . Lipofectin at 10 µg/ml, by itself, caused a significant increase in BrdU labeling of control cultures (Table 2) . But this concentration of lipofectin is required to optimize entry of ODNs into the cell, as shown in Fig. 3 .
Discussion
FGF2 and FGF1 are the prototypes of the large family of FGFs (Burgess & Maciag 1989) , presently consisting of 20 members (Nishimura et al. 2000) that are widely expressed in embryo, fetus and adult tissues of vertebrates and invertebrates. It has been recognized for years that forms of Miralles et al. 1999) . For instance, FGF2 has long been considered a candidate to participate in the control of fetal development of adrenal glands and, also, of growth and function of the adult adrenal cortex (Mesiano et al. 1991) .
Here we show that FGF2 elicits a strong mitogenic response in G 0 /G 1 -arrested Y1 adrenocortical cells, measured by BrdU labeling (Fig. 1) , that linearly correlates with an early cFos induction (Fig. 2) , implying a causeeffect relationship. We previously reported (Lotfi et al. 1997 ) that short pulses of ACTH, but not sustained treatment, resemble FGF2, inducing cFos and stimulating DNA synthesis in G 0 /G 1 -arrested Y1 cells. In sharp contrast with FGF2, ACTH dose-response curves for cFos induction and DNA synthesis stimulation are not correlated (Fig. 2b and c) , suggesting that the cFos protein might not be a mediator in the growth response promoted by this hormone. To test whether induction of fos and jun genes are necessary for cell entry into S-phase stimulated by ACTH and FGF2, we blocked cFos and cJun protein synthesis with antisense phosphorotioate ODNs.
In principle, the antisense ODN technique affords the highest possible selectivity for blocking mRNA translation, thanks to the specificity of Watson-Crick base pairing between the antisense ODN and its respective mRNA. Phosphorotioate ODNs are resistant to cellular nucleases and association of ODN with cationic liposomes promotes cell entry, rendering the antisense ODN technique an efficacious approach to suppress synthesis of specific proteins (Wagner 1994) . We tested cfos and cjun antisense and sense 18-mers sequences that have worked well for others to suppress cFos and cJun expression (Colotta et al. 1992) . In Y1 adrenocortical cells, this cfos antisense ODN efficaciously inhibited cFos protein synthesis (Table 1 and Fig. 3) . We have not directly monitored cJun protein synthesis, but presumably cJun synthesis was also inhibited by an antisense effect with the cjun antisense ODN used. In addition, cfos and cjun antisense ODNs blocked DNA synthesis stimulation by FGF2 and ACTH (Table 2 and Fig. 4) .
Others (Guvakova et al. 1995) have reported that phosphorotioate ODNs can bind FGF2 preventing its association to receptors and, consequently, inhibiting its activity. This non-specific interaction between ODNs and FGF2 is unlikely to be important in our experiments. First, except for the cfos antisense, all other ODNs do not inhibit cFos induction by FGF2 (Table 1) . Secondly, cfos or cjun sense had no effect on DNA synthesis stimulation by FGF2 (Table 2) . Thirdly, in our laboratory, several sense phosphorotioate ODNs for cyclin D1 and c-myc mRNAs were tested and none of them have shown inhibition of FGF2 activity (A P Lepique, T T Schwindt & H A Armelin, unpublished observations). Fourthly, in our procedures ODNs are first complexed with lipofectin before addition to the culture medium (see Materials and Methods); under these conditions ODNs are trapped in ODN-lipofectin complexes and are unlikely to be available for interaction with FGF2. Altogether, these results suggest that we are efficaciously blocking both cFos Table 1 Inhibition of cFos protein induction by cfos-antisense phosphorotioate ODN in G 0 /G 1 -arrested Y1 adrenocortical cells. Y1 cells seeded on coverslips, G 0 /G 1 -arrested in SFM, were incubated for 4 h with ODN-lipofectin complex, then treated for 2 h with either 1 g/ml corticotropin A or 1 nM FGF2, rinsed with PBS and fixed with 3·7% formaldehyde. cFos-stained nuclei were estimated by an immunocytochemical reaction with antibody for the mouse cFos protein. In controls, untreated cells, cFos staining is negligible; 3800-4800 nuclei and 1060-1550 nuclei were counted for each condition of respectively corticotropin A-and FGF2-treated cells. These results were pooled from two sets of four and two independent experiments for, respectively, corticotropin A and FGF2 protein induction and DNA synthesis stimulation by an antisense mechanism. cfos or cjun antisense ODNs are sufficient to completely abolish stimulation of DNA synthesis by ACTH, but not by FGF2 (Fig. 4) . Only a combination of both cfos and cjun antisense ODNs can extinguish DNA synthesis stimulated by FGF2 in G 0 /G 1 -arrested Y1 cells (Fig. 4) . These results are not surprising, since Kovary & Bravo (1991b) have shown that only micro-injections of combinations of antibodies against Fos and Jun proteins can block G 1 -phase traversing in G 0 -arrested mouse 3T3 fibroblasts growth stimulated with serum.
Ratio
Thus, the results of our antisense experiments support the notion that the induction of cFos and cJun proteins is a necessary step in the triggering mechanisms by which ACTH or FGF2 drives G 0 /G 1 -arrested Y1 cells to enter Table 2 Inhibitory effects of c-fos and c-jun antisense phosphorotioate ODNs on DNA synthesis stimulated by 2 h pulses of respectively FGF2 and corticotropin A in G 0 /G 1 -arrested Y1 adrenocortical cells. Y1 cells seeded on coverslips and G 0 /G 1 -arrested in SFM for 48 h, were incubated for 4 h with ODN-lipofectin complex (0·1 M ODN : 10 M lipofectin), before treatment with 1 g/ml corticotropin A and 1 nM FGF2 between 0 and 2 h. After treatment, coverslips were rinsed and incubated in fresh SFM plus the respective ODN-lipofectin complex. BrdU (100 M) was incorporated between 12 and 24 h. At 24 h cells were fixed and processed to estimate percent BrdU-labeled nuclei. Index of DNA synthesis stimulation as defined in legend of Fig. 1 (Lotfi et al. 1997 (Lotfi et al. , 2000 . In addition, we have previously reported that the weak mitogenic effect of ACTH 39 does not depend on the cAMP/PKA pathway (Lotfi et al. 1997) .
FGF2
On the other hand, one must keep in mind that ACTH behaves as a strong anti-mitogen in cultures of adrenocortical cells from a variety of species (Hornsby 1985) . How can we mechanistically reconcile this strong antimitogenic action of ACTH with its weak mitogenic effect that we are focusing on in this report? In Y1 adrenal cells, this ACTH anti-mitogenic effect is dependent on the cAMP/PKA pathway (Masui & Garren 1971 , Rae et al. 1979 , Lotfi et al. 1997 . But the mechanisms underlying ACTH anti-mitogenic effects are still essentially unknown. We recently observed three cAMP/PKAdependent effects of ACTH concurring to block Y1 cell cycle at G 1 -phase, namely: (i) degradation of the cMyc protein (Lepique et al. 2000) ; (ii) dephosphorylation/ deactivation of the Akt/PKB enzyme (Forti & Armelin 2000) ; and (iii) induction of the p27 Kip1 protein, an inhibitor of cyclin-dependent kinases (T. Schwindt, F. Forti & H. Armelin, unpublished observations). In conclusion, ACTH receptors initiate signals leading to dual effects promoting and inhibiting cell cycle progress. It remains to be explained how these antagonistic effects of ACTH are balanced to regulate growth and function of the adrenal cortex. Studies on the interactions between ACTH and FGF2 in G 0 /G 1 -arrested Y1 adrenocortical cells are useful to elucidate circuits that integrate signals initiated in respectively ACTH receptors and FGF2 receptors that should be relevant to the mechanisms underlying regulation of the G 0 <G 1 <S transition in adrenal cell cycle.
